close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval
Tags Biotechnology Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Wegovy maker Novo Nordisk's sales hike in second quarter
Tags Pharmaceuticals Europe News Breaking News: Europe
From CNBC.com News
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
Tags Pfizer Inc Health care industry CVS Health Corp
From CNBC.com News
Hims & Hers stock falls 10% on revenue miss
Tags Health care industry Health & Science Technology
From CNBC.com News
Cramer's week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald's
Tags Mad Money MP Materials Corp McDonald's Corp
From CNBC.com News
Trump's drug price ultimatum sets pharma firms scrambling
Tags Trade AstraZeneca PLC Gilead Sciences Inc
From CNBC.com News
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
Tags Novo Nordisk A/S Breaking News: Business Health & Science
From CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
Tags Biotech and Pharmaceuticals Amgen Inc Pharmaceuticals
From CNBC.com News
Shares of Novo Nordisk plunge 15% after Wegovy-maker cuts full-year guidance
Tags Breaking News: Europe Pharmaceuticals Europe News
From CNBC.com News
Healthy Returns: Researchers move closer to a universal cancer vaccine
Tags Merck & Co Inc Omada Health Inc Teladoc Health Inc
From CNBC.com News
Europe’s most valuable firm SAP flags U.S. trade slowdown but says Japan deal gives 'hope'
Tags Breaking News: Economy Europe Economy Earnings reports
From CNBC.com News
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
Tags Biotech and Pharmaceuticals Biotechnology Breaking News: Business
From CNBC.com News
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
Tags Social issues Healthy Returns Regeneron Pharmaceuticals Inc
From CNBC.com News
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Tags US: News Business News Companies
From CNBC.com News
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
Tags Health & Science Pfizer Inc Health care industry
From CNBC.com News
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Tags LILLY DRN Health care industry Biotech and Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Business Markets Hims & Hers Health Inc
From CNBC.com News
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
Tags Hims & Hers Health Inc Business Companies
From CNBC.com News
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
Tags Healthy Returns Social issues Health & Science
From CNBC.com News
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Tags Business Social issues Business News
From CNBC.com News
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
Tags Business Companies Business News
From CNBC.com News
Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price
Tags Novo Nordisk A/S Breaking News: Europe Pharmaceuticals
From CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
Tags International: Top News And Analysis AstraZeneca PLC GSK plc
From CNBC.com News
Why Americans pay so much more for prescription drugs
Tags Biotechnology Novo Nordisk A/S Politics
From CNBC.com News
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Tags Healthy Returns Social issues Novo Nordisk A/S
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags Abbvie Inc Trade AstraZeneca PLC
From CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
Tags Make It / Money Hims & Hers Health Inc Make It
From CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
Tags Enterprise Hims & Hers Health Inc Internet
From CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
Tags U/S/ Markets Stock markets DoorDash Inc
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Abbvie Inc Merck & Co Inc Roche Holding AG
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today